Cutler Group LP Fsd Pharma Inc. Put Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Jul 19, 2021
SELL
$1.56 - $2.13 $7,176 - $9,798
-4,600 Reduced 63.01%
2,700 $2,000
Q1 2021

Apr 26, 2021
BUY
$1.65 - $3.87 $12,045 - $28,251
7,300 New
7,300 $3,000

About FSD Pharma Inc.

HUGE Quotes by TradingView
  • Ticker HUGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 38,218,100
  • Market Cap $146M
  • Description
  • FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...
More about HUGE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email